Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes

Clinical trial NCT00389415 · COMPLETED

Trial details

NCT number: NCT00389415
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2006-10-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.